The largest database of trusted experimental protocols

7 protocols using rea control s pe

1

Flow Cytometric Analysis of CD220 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Untreated, cholesterol depleted, and sterol replaced HEK 293T cells were prepared as described above in 60 mm dishes. Cells were washed with Blocking Buffer (0.5% BSA, 2 mM EDTA in PBS) and incubated with CD220-PE (130-103-717, Miltenyi Biotec) or REA Control (S)-PE (130-113-438, Miltenyi Biotec) for 10 min. Cells were washed in Blocking Buffer, fixed in 1% paraformaldehyde in PBS for 15 min on ice, and washed in PBS. Flow cytometry analysis was performed on a BD FACS Calibur.
+ Open protocol
+ Expand
2

Gingival Fibroblast Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mesenchymal character of isolated gingival fibroblasts was confirmed by investigating the presence of the following surface markers: CD44, CD90, and CD105 with a FACScan flow cytometer (Becton Dickinson, San Jose, CA, USA). The following antibodies were used: CD44-PE (human, 130-113-897); CD90-FITC (human, clone: REA897, 130-114-901); CD105-APC (human, clone: REA794, 130-112-324) and REA Control (S)-PE (130-113-438), REA Control (S)-FITC (130-113-437), REA Control (S)-FITC (130-113-437), REA Control (S)-APC (130-113-434) and REA Control (S)-PE (130-113-438) from Miltenyi Biotec (Bergisch Gladbach, Germany). The data were analyzed using CellQuest Pro Software (Becton Dickinson, San Jose, CA, USA, version 5.2.1).
+ Open protocol
+ Expand
3

Synthesis and Characterization of ANTP266

Check if the same lab product or an alternative is used in the 5 most similar protocols
ANTP266 2-((4-methoxyphenyl)sulfonamido)-3-(6-(2-(piperazin-1-yl)ethoxy)naphthalene-2-yl) propanoic acid was synthesized by Zhiyu Li (China Pharmaceutical University, China) and was dissolved in DMSO as a stock solution and stored at −20 °C. PE-conjugated anti-human CD62P, FITC-conjugated anti-human CD42a, REA Control (S)-PE, and REA Control (S)-FITC were from MiltenyiBiotec (Koln, Germany). The collagen was from Hyphen BioMed (Neuville sur Oise, France). Sepharose 2B beads, Aspirin, ADP, thrombin, U46619, human fibrinogen, apyrase, prostaglandin E1 (PGE1), [N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid] (HEPES), biocytin, FITC-conjugated phalloidin, and anti-mouse IgG-conjugated alkaline phosphatase were purchased from Sigma Chemical Co. (St. Louis, MO, USA).
+ Open protocol
+ Expand
4

Synthesis and Application of ND-1 Compound

Check if the same lab product or an alternative is used in the 5 most similar protocols
ND-1 (2-butyramido-3-(6-((4-carbamimidoylbenzyl)oxy)naphthalen-2-yl)propanoic acid) was synthesized by Zhiyu Li (China Pharmaceutical University, China) and was dissolved in DMSO as a stock solution, stored at −20°C. Aspirin, ADP, thrombin, U46619, human fibrinogen, apyrase, prostaglandin E1 (PGE1), FITC-conjugated phalloidin, and anti-mouse IgG-conjugated alkaline phosphatase were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Collagen was from Hyphen BioMed (Neuville sur Oise, France). Purified human platelet integrin αIIbβ3 and the mouse anti-human integrin β3 antibody were from Enzyme Research Laboratories (South bend, IN, USA) and Millipore (Temecula, CA, USA), respectively. PE-conjugated anti-human CD62P, FITC-conjugated anti-human CD42a, REA Control (S)-PE, and REA Control (S)-FITC were from Miltenyi Biotec (Koln, North Rhine-Westphalia, Germany).
+ Open protocol
+ Expand
5

Insulin Receptor Alpha Chain Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
After lipid exchange as described above, cells were dislodged from plates using enzyme-free cell dissociation solution (Millipore), spun down at 300g, 4 °C for 5 min, and washed with blocking buffer (0.5% BSA, 2 mM EDTA in PBS) at room temperature. Manufacturer’s protocol was followed for fluorescent antibody staining. Cells were resuspended in 100 μl blocking buffer, CD220-PE antibodies against IR alpha chain or recombinant antibody (REA) control (S)-PE (Miltenyi Biotech) were added, and the samples were incubated at 4 °C in the dark for 10 min. Samples were washed at room temperature in PBS blocking buffer again. Flow cytometry analysis was performed using FACSCalibur (BD Bioscience) collecting 10,000 events per sample. Data was analyzed using FlowJo version 10 software.
+ Open protocol
+ Expand
6

Examining CB-ECFC Inflammatory Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
CB-ECFCs were pre-treated for 24 h with 0.01, 0.1, 1, 10, 50 and 100 ng/ml of TNFα. Untreated CB-ECFCs from the same donors and passages were used as control group. Then, cells were detached using cell dissociation reagent TrypLE (Gibco) and proceeded to immunostaining using mixes of following antibodies: FITC-anti-CD31, VioBlue-anti-CD144, PE-Vio770-anti-VEGFR2 (KDR), APC-anti-TNFR1, PE-anti-TNFR2, APC-anti-ICAM (CD54), PE-anti-VCAM (CD106), APC-anti-TIE2 (CD202b), REA control (s)-APC, REA control (s)-PE (Miltenyi-Biotec). Events acquired on a LSRFORTESSA flow cytometer (BD-Biosciences) and analyzed using FlowJo software v10 (FlowJo-LLC).
+ Open protocol
+ Expand
7

Phenotypic Characterization of Differentiated Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were harvested after differentiation and washed thrice in autoMACS running buffer (Miltenyi Biotec, #130-091-221, Gladbach, Germany). Cells were transferred to 96-well plates with 2 × 105 cells for each antibody panel. Cells were stained with the following antibodies: diluted 1:50, REA Control (S)-VioGreen (Miltenyi Biotec, #130-113-444), REA Control (S)-PE (Miltenyi Biotec, #130-113-438), REA Control (S)-APC (Miltenyi Biotec, #130-113-434); REA Control (S)-PE-Vio770, (Miltenyi Biotec, #130-113-440); HLA-DR-VioGreen (Miltenyi Biotec, #130-111-795), CD54-APC (Miltenyi Biotec, #130-121-342); CXCR4-PE-Vio770 (Miltenyi Biotec, #130-116-161); CD11b-VioGreen (Miltenyi Biotec, #130-110-617); CD83-PE (Miltenyi Biotec, #130-110-561); CD86-APC (Miltenyi Biotec, #130-116-161) for 10 min at 4 °C in the dark. Afterwards, cells were washed thrice with autoMACS running buffer and stained with DAPI (Sigma, #D9542), to exclude dead cells for the determination of the cell viability.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!